
Scientific and Medical Information for Professionals
Our team is committed to providing U.S. healthcare professionals with accurate and current scientific information about Acadia products, and our research and development efforts to help address unmet medical needs.

Areas of Focus
Acadia is advancing care in neurological disorders and rare diseases with therapies that redefine options for patients and families who have few or none. Our areas of focus include Parkinson’s disease psychosis, Alzheimer’s disease psychosis, Rett syndrome and more.
Parkinson’s Disease Psychosis (PDP)
PDP is typically characterized by hallucinations and delusions. Around 50% of patients with Parkinson’s disease may experience hallucinations and/or delusions over the course of their disease.

Alzheimer’s Disease Psychosis (ADP)
Approximately 6 million people in the United States are living with Alzheimer’s disease, with this number projected to rise as the elderly population grows. Hallucinations and delusions associated with ADP affect around 30% of patients with AD dementia.

Rett Syndrome (RTT)
RTT is a rare neurodevelopmental disorder that occurs primarily in females following apparently normal development for the first 6-18 months of life. RTT occurs worldwide in approximately one of every 10,000 to 15,000 female births (6,000 to 9,000 patients in the U.S.).

Scientific Publications
In collaboration with leading experts, Acadia pursues scientific discovery in neurological disorders and rare diseases. Explore our peer-reviewed publications to learn more about the research driving our innovations.

Resources
We’re here to support the medical community in their work. Click to explore our collection of resources, from info on clinical trials to our independent medical education grants.

Discover Acadia-funded grants for independent medical education.

Find information on Acadia-supported investigator-initiated studies.
Get in Touch
How can we help? Click here to get in touch with us directly. Our team is committed to supporting you.